Michel Voigt Biography and Net Worth



Mike Voigt joined Merit in 2020 with more than 20 years of progressive global human resources (HR) leadership experience in diverse industries, including medical device, pharmaceutical, and technology. Voigt has led successful organizational transformation efforts on a global scale and has deep expertise within strategic HR business partnering, global HR leadership, HR services, cultural development, organizational design, compensation, M&A, and recruiting.

Prior to Merit, Voigt was Chief Human Resources Officer at Mavenir, a rapidly growing global technology company. Prior to Mavenir, he worked at Galderma for nine years where he held multiple HR roles in the U.S., France, and Switzerland.

Voigt holds a bachelor’s degree in Business Administration from Oklahoma State University.

What is Michel James Voigt's net worth?

The estimated net worth of Michel James Voigt is at least $37,996.70 as of March 14th, 2023. Mr. Voigt owns 515 shares of Merit Medical Systems stock worth more than $37,997 as of April 27th. This net worth estimate does not reflect any other investments that Mr. Voigt may own. Learn More about Michel James Voigt's net worth.

How old is Michel James Voigt?

Mr. Voigt is currently 51 years old. There are 5 older executives and no younger executives at Merit Medical Systems. The oldest executive at Merit Medical Systems is Mr. Fred P. Lampropoulos, Founder, Chairman, CEO & President, who is 74 years old. Learn More on Michel James Voigt's age.

How do I contact Michel James Voigt?

The corporate mailing address for Mr. Voigt and other Merit Medical Systems executives is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. Merit Medical Systems can also be reached via phone at (801) 253-1600 and via email at [email protected]. Learn More on Michel James Voigt's contact information.

Has Michel James Voigt been buying or selling shares of Merit Medical Systems?

Michel James Voigt has not been actively trading shares of Merit Medical Systems during the last ninety days. Most recently, Michel James Voigt sold 2,000 shares of the business's stock in a transaction on Tuesday, March 14th. The shares were sold at an average price of $68.31, for a transaction totalling $136,620.00. Following the completion of the sale, the insider now directly owns 515 shares of the company's stock, valued at $35,179.65. Learn More on Michel James Voigt's trading history.

Who are Merit Medical Systems' active insiders?

Merit Medical Systems' insider roster includes A. Anderson (Director), Jill Anderson (Director), David Floyd (Director), Ronald Frost (COO), Fred Lampropoulos (CEO), Brian Lloyd (Insider), F. Millner (Director), Raul Parra, Jr. (CFO), Neil Peterson (COO), Michel Voigt (Insider), Lynne Ward (Director), and Joseph Wright (Insider). Learn More on Merit Medical Systems' active insiders.

Are insiders buying or selling shares of Merit Medical Systems?

In the last twelve months, insiders at the medical instruments supplier sold shares 6 times. They sold a total of 99,817 shares worth more than $7,434,244.71. The most recent insider tranaction occured on March, 12th when CFO Raul Jr. Parra sold 6,480 shares worth more than $479,196.00. Insiders at Merit Medical Systems own 3.7% of the company. Learn More about insider trades at Merit Medical Systems.

Information on this page was last updated on 3/12/2024.

Michel James Voigt Insider Trading History at Merit Medical Systems

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/14/2023Sell2,000$68.31$136,620.00515View SEC Filing Icon  
See Full Table

Michel James Voigt Buying and Selling Activity at Merit Medical Systems

This chart shows Michel James Voigt's buying and selling at Merit Medical Systems by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Merit Medical Systems Company Overview

Merit Medical Systems logo
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
Read More

Today's Range

Now: $73.78
Low: $73.40
High: $74.21

50 Day Range

MA: $74.52
Low: $70.99
High: $80.48

2 Week Range

Now: $73.78
Low: $62.58
High: $85.62

Volume

283,441 shs

Average Volume

311,344 shs

Market Capitalization

$4.28 billion

P/E Ratio

45.54

Dividend Yield

N/A

Beta

0.89